These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17846012)

  • 1. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
    Farace F; Bidart JM
    Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial cells as biomarkers in clinical oncology.
    Mancuso P; Bertolini F
    Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells.
    Bertolini F
    Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
    Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
    Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
    Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
    Bertolini F; Shaked Y; Mancuso P; Kerbel RS
    Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
    Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
    Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization.
    Hunting CB; Noort WA; Zwaginga JJ
    Vox Sang; 2005 Jan; 88(1):1-9. PubMed ID: 15663716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
    Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.
    Jacques N; Vimond N; Conforti R; Griscelli F; Lecluse Y; Laplanche A; Malka D; Vielh P; Farace F
    J Immunol Methods; 2008 Sep; 337(2):132-43. PubMed ID: 18662694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
    Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
    Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bone marrow constitutes a reservoir of pericyte progenitors.
    Lamagna C; Bergers G
    J Leukoc Biol; 2006 Oct; 80(4):677-81. PubMed ID: 16888086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells in breast cancer patients.
    Richter-Ehrenstein C; Rentzsch J; Runkel S; Schneider A; Schönfelder G
    Breast Cancer Res Treat; 2007 Dec; 106(3):343-9. PubMed ID: 17972175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications.
    Le Bourhis X; Romon R; Hondermarck H
    Breast Cancer Res Treat; 2010 Feb; 120(1):17-24. PubMed ID: 20033768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells in tumor angiogenesis.
    Fang S; Salven P
    J Mol Cell Cardiol; 2011 Feb; 50(2):290-5. PubMed ID: 21047516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surrogate marker to monitor angiogenesis at last.
    Schneider M; Tjwa M; Carmeliet P
    Cancer Cell; 2005 Jan; 7(1):3-4. PubMed ID: 15652744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.